Localized cardiomyocyte lipid accumulation is associated with slowed epicardial conduction in rats

Simon P. Wells, Antonia J.A. Raaijmakers, Claire L. Curl, Christopher O’Shea, Sarah Hayes, Kimberley M. Mellor, Jonathan M. Kalman, Paulus Kirchhof, Davor Pavlovic, Lea M.D. Delbridge*, James R. Bell*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article numbere202213296
Number of pages10
JournalJournal of General Physiology
Volume155
Issue number11
Early online date3 Oct 2023
DOIs
Publication statusPublished - 6 Nov 2023

Bibliographical note

Acknowledgments:
Jeanne M. Nerbonne served as editor.

MATLAB script for the generation of activation maps and conduction velocity analysis was kindly provided by Professor Cesare Terracciano, Imperial College London (London, UK), and is gratefully acknowledged. Technical support was provided by the Melbourne Histology Platform.

This research was supported by the National Health and Medical Research Council (grants #1099352 and #1125453; to L.M.D. Delbridge and J.R. Bell) and the Australian Research Council (grant #DP160102404; to L.M.D. Delbridge). D. Pavlovic is supported by the British Heart Foundation (PG/17/55/33087; RG/17/15/33106; FS/19/12/34204; FS/19/16/34169). C. O’Shea is supported by a Sir Henry Wellcome Fellowship, Wellcome Trust, 221650/Z/20/Z.

Author contributions: S.P. Wells, D. Pavlovic, L.M.D. Delbridge, and J.R. Bell designed the research; S.P. Wells, A.J.A. Raaijmakers, S. Hayes, and J.R. Bell performed experiments; S.P. Wells, A.J.A. Raaijmakers, C.L. Curl, C. O’Shea, S. Hayes, and J.R. Bell analyzed data; and S.P. Wells, K.M. Mellor, J.M. Kalman, L.M.D. Delbridge, and J.R. Bell wrote the paper. All authors approved the final version of the manuscript.

Disclosures: J.M. Kalman reported grants from Medtronic Inc., Biosense Webster, and Zoll outside the submitted work; and Practitioner Fellowship, National Health and Medical Research Council of Australia. P. Kirchhof reported grants from DZHK, BHF, and EU during the conduct of the study, and grants from several companies active in atrial fibrillation outside the submitted work; in addition, P. Kirchhof had a patent to two patents owned by UKE granted issued. No other disclosures were reported.

Cite this